Health Research Authority (HRA) changes – Cohort 3 going live 30 November

Here is the latest update in the HRA’s Approval process of rolling out a new system for approving research in the NHS in England, which will replace existing arrangements for NHS Permission/ Assurance.  The HRA will assess regulatory compliance and NHS organisations wil confirm their capacity and capability to support studies.

This process is being implemented in phases, currently the following studies are eligible for HRA Approval:

  • Cohort I Health Services Research (staff research)
  • Cohort 2 launched on 10th August 2015 -primary care studies in England (studies live only in primary care settings).

Cohort 3 goes live 30th November 2015

  • This cohort is for non-interventional research led from England which is happening across NHS sectors (ie studies excluding clinical trials, clinical investigations)

Studies which are single site or which are primarily educational are excluded

For anyone who is planning a REC/R&D submission for a primary or community care or a primary care only study which will be led locally please contact the HRA before you submit to HRA / Research Ethics Committee so they can best support your application.

Engage with your lead NHS R&D Office

Studies going via HRA Approval have specific guidance and this requires engagement with your lead NHS R&D office and the Clinical Research Network to ensure the logistics and costings relating to research delivery are worked up before any submission to REC/HRA goes in .

For more information please see the HRA Approval website 

Guidance from the NIHR Cambridgeshire Primary & Community Care Research Office

The primary and community care R&D office based in Cambridge has developed guidance for researchers applying for HRA approval in primary and community care.

You can access this guidance via their website (please use Chrome or Firefox for access)



Related news:

Share this article
Tweet about this on Twitter